kitosdad
- 12 Dec 2007 16:20
The engines have fired up at last for MDX. ( BPRG ) At long last they are being recognised for the force they will become over the next two years. On the cusp of disclosing huge revenue-earning deals with Global pharmacists. These have been hinted at as being unrolled before the years end, but may be in the next days.You still have time to get in at a bargain-basement price before the SP takes off for real shortly.
kitosdad
- 04 Jan 2008 09:06
- 27 of 8631
GB ... you don't really expect any positve comments to have a decent response do you?. But as you say, it's all in black and white, and THAT is indisputable.
Wishbone
- 04 Jan 2008 09:25
- 28 of 8631
Thanks for that Greedybas.
Dil
- 04 Jan 2008 09:26
- 29 of 8631
ooooo slap me wrist
Fred1new
- 04 Jan 2008 14:16
- 30 of 8631
The show goes on for Meldex
Created:
31 December 2007
Updated:
2 January 2008
Written by:
Richard Hemming
Meldex's wild run continues. Trading at 60p, its shares have fallen over 30 per cent from a high of 94p on 10 December. But it has been business as usual at the speciality pharmaceutical provider.
It has announced licence agreements for three products and an increase in demand for its unregulated anti-smoking product. It has also acquired three antibiotic products for 14.5m (10.6m), financed by a combination of paper and cash.
--------------------------------------------------------------------------------
IC View
Buy
Despite the share price fall, the Meldex story remains on track. The company has strong earnings growth and Nomura Code's valuation of 115p is almost double the current share price. At 60p, the shares are a buy.
greedybas
- 05 Jan 2008 08:29
- 31 of 8631
Nomura code have upgrded their valuation from 122p to 146p. In their latest brokers note.
Download Nomura Code Brokers note 02/01/2008
Thanks to inghu from the adv site :-) for publishing this
Dil
- 05 Jan 2008 08:34
- 32 of 8631
Oh gawd if the IC tipped it Fred it must be a short :-)
greedybas
- 06 Jan 2008 19:18
- 33 of 8631
I see that slimthru has the sold out sign on the boots website.
boots -slimthru
Dil
- 07 Jan 2008 09:33
- 34 of 8631
Distribution problems I guess.
Fred1new
- 07 Jan 2008 10:35
- 35 of 8631
DIL, Have another mince pie!
I would like to know what the ballance of shorts are at the moment.
I think like TAN many sitting on decent profits have cashed in due to the choppy waters the market are in at the moment. I wish I had and then had enough sense to hold and buy back at the right price.
The products that MELDEX are pushing have a huge potential and the method of delivery are advanced. If I had cash I would top up, but not sure at what price.
From fundamentals a buy from charts suggest it could drop back to 48p. but the problem at the moment is whether there are any lying Bs still on the board. I don't think so.
For the time being I am going to hold and epect the price to be above 120p later this year!
Good luck.
PS I think there "should" be a weekly list of shorts and longs on all small companies.
Dil
- 07 Jan 2008 11:33
- 36 of 8631
Hi Fred :-)
The likely cause imo is that companies try to minimise stocks at year end and therefore only order barely enough to manage on. Manufacturing shut down for a period of around 10 days at Christmas and therefore new supplies would not be immediatley available (manufacturer would also run down stocks at year end).
The above is done for accounting purposes and has f*ck all to do with the real demand for the product.
On the other hand Boots may have decided to stop stocking it.
greedybas
- 07 Jan 2008 19:13
- 37 of 8631
Dil
really,
Peak time for Slimming products is this time of year. I was in my local boots on Friday and there were 16 packs of the large boxes of slimthru and today there were 4 so the promotion is going very well based on my crude observation.
they are also selling in Tesco and holland & barrett.
Anyway this is a very small part of Meldex and the strong trading update due within weeks should show how rapid the growth is.
Dil
- 08 Jan 2008 10:31
- 38 of 8631
Yes really greedybas .... welcome to the real world. Boots would be more interested in stock turnover ratios , turn rates etc than being over stocked with anything especially non essentials at month end time whether in store or online.
Fred1new
- 08 Jan 2008 16:54
- 39 of 8631
Dill, Just a thought:- Wouldn't some Slimthru be better for you than another Mince pie.
If you do go down to Boots you can get me a supply of Prozac. I may help me a little when I look at my portfolio.
8-)
greedybas
- 08 Jan 2008 19:08
- 40 of 8631
Dil
retailers reduce/increase stock per product type. It is not a case of the calendar year end = run down all stock.
I would say boots reduce chocolates, perfumes, gift sets..etc
increase slimming products, fitness aids, cough flu medicines,....
anyway slimthru is a small part of meldex and Dil and Goldfinger are either shorting this or are looking for a cheaper entry point!!! or else why post here. Nothing they have posted has been of substance.
ptholden
- 08 Jan 2008 22:25
- 41 of 8631
Dil rarely posts anything of substance, you have to read between the lines ;)
Dil
- 09 Jan 2008 10:14
- 42 of 8631
Luckily for me Fred I don't like mince pies :-)
greedybas .... thats what they all said years ago at 140p when I said it was worth 50p tops , go read the threads.
Fred1new
- 09 Jan 2008 11:18
- 43 of 8631
To keep Dil happy!
They must be reading your post.
This is about the only good news I jave had today.
Subject: Production & sales stats.
Date: Wed 9th Jan 2008 7:43:50
Country: UK
Industry: Pharmaceuticals & Biotechnology
Company: Meldex International PLC
Meldex Intl says Dexo Italy to launch 7 new products in Q1
LONDON (Thomson Financial) - Meldex International PLC said its Dexo Italy operation will launch seven new products in the first quarter, which will bolster its existing product portfolio of prescription products licensed from GSK and Pfizer.
The specialty pharmaceutical and healthcare company said together the new product launches in Italy are expected to contribute revenues in excess of 12 mln eur over the next three years, in line with the current business plan to develop the Dexo operation.
Three of the products have been licensed from AD Pharma including liver detoxicant Atox, cholesterol drug Antisterol, and Floract, which provides a rebalance of the intestinal flora.
Dexo will also launch four products currently marketed in France, the group said. These include artificial saliva Hypozalix, Ronflux - to help reduce snoring, Calme - a drug to promote balanced serotonin levels and Gel Circulatoire to help soothe muscle cramps and rheumatic pains in the legs.
TFN.newsdesk@thomson.com
npr/lam
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
www.afxpress.com
scotinvestor
- 09 Jan 2008 11:22
- 44 of 8631
but shares still down.........any time good news on mdx, then shares get stuffed.
no news for ages and shares go from 40 to 94p.
LOTS OF GOOD NEWS for last few weeks and guess what......sp down to about 50p
very strange
Dil
- 09 Jan 2008 11:38
- 45 of 8631
Get me a bottle of the liver detox stuff Fred.
chocolat
- 09 Jan 2008 11:56
- 46 of 8631
And a good dose of Ronflux, I'd have thought.